Tryptophan–kynurenine metabolites associate with inflammation and immunologic phenotypes in common variable immunodeficiency
Journal of Allergy and Clinical Immunology · 2025-09 · 156 (3) · 814-824.e11
DOI: 10.1016/j.jaci.2025.04.031 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Allergy and Clinical Immunology, 2025-09. Verfasst von Silje F Jørgensen und 11 weiteren Autor:innen. Beteiligte Einrichtung: Research Institute of Internal Medicine, Oslo University Hospital Rikshospitalet, Oslo, Norway; Section of Clinical Immunology and Infectious Disease…. Hauptthemen laut MEDLINE: Tryptophan, Kynurenine, Common Variable Immunodeficiency, Inflammation. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 59 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: ERC, European Research Council, South-Eastern Norway Regional Health Authority.
Abstract (Originalsprache)
BACKGROUND: A large proportion of patients with common variable immunodeficiency (CVID) have autoimmune and inflammatory manifestations characterized by chronic T-cell- and monocyte/macrophage activation of unknown etiology. The tryptophan-kynurenine pathway has previously been linked to immune activation involving T cells and monocytes/macrophages, as well as with gut microbial dysbiosis in some inflammatory diseases. OBJECTIVE: We aimed to characterize the tryptophan-kynurenine pathway in CVID and its potential association with clinical/immunologic phenotype and gut microbial dysbiosis. METHODS: Serum concentrations of a set of tryptophan-kynurenine pathway metabolites and neopterin were measured using liquid chromatography-tandem mass spectrometry in a discovery cohort (n = 40), a validation cohort (n = 53), and healthy controls (n = 60). B-cell phenotype was analyzed in both cohorts, whereas inflammatory markers (enzyme immunoassay), lipopolysaccharide, gut microbial composition, and food frequency questionnaire were measured in the discovery cohort. RESULTS: Compared to healthy controls, CVID patients had increased metabolism of the tryptophan-kynurenine pathway as assessed by increased kynurenine/tryptophan ratio, quinolinic acid, and 3-hydroxykynurenine in both the discovery and validation cohorts. The findings were most pronounced in the subgroup with autoimmune/inflammatory complications but was to some degree also observed in CVID patients with infection only. In CVID, the metabolites in the tryptophan-kynurenine pathway associated with soluble (s) markers of monocyte (sCD14, sCD163, neopterin) and T-cell (sCD25) activation as well as B-cell phenotype (eg, naïve B cells). Individual gut microbial taxa may influence tryptophan-kynurenine pathway metabolites, but not lipopolysaccharide or diet. CONCLUSION: We found altered levels of several metabolites in the tryptophan-kynurenine pathway in two different CVID cohorts associated with systemic inflammation and B-cell phenotype.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Research Institute of Internal Medicine, Oslo University Hospital Rikshospitalet, Oslo, Norway; Section of Clinical Immunology and Infectious Diseases, Oslo University Hospital Rikshospitalet, Oslo, Norway. Electronic a…
- Research Institute of Internal Medicine, Oslo University Hospital Rikshospitalet, Oslo, Norway; Norwegian PSC Research Center, Department of Transplantation Medicine, Division of Surgery, Inflammatory Diseases and Trans…
- Research Institute of Internal Medicine, Oslo University Hospital Rikshospitalet, Oslo, Norway; Institute of Clinical Medicine, University of Oslo, Oslo, Norway; Thrombosis Research Center (TREC), Division of Internal M…
- Research Institute of Internal Medicine, Oslo University Hospital Rikshospitalet, Oslo, Norway; Section of Clinical Immunology and Infectious Diseases, Oslo University Hospital Rikshospitalet, Oslo, Norway; Institute of…
- Research Institute of Internal Medicine, Oslo University Hospital Rikshospitalet, Oslo, Norway; Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
- Department of Immunology, Oslo University Hospital Rikshospitalet, Oslo, Norway.
Förderung
- ERC
- European Research Council
- South-Eastern Norway Regional Health Authority
Zitieren
APA
Jørgensen, S. F., Braadland, P. R., Ueland, T., Fraz, M. S. A., Michelsen, A. E., Holm, K., Osnes, L. T., Trøseid, M., Ueland, P. M., Fevang, B., Aukrust, P., & Hov, J. R. (2025). Tryptophan–kynurenine metabolites associate with inflammation and immunologic phenotypes in common variable immunodeficiency. Journal of Allergy and Clinical Immunology, 156(3), 814-824.e11. https://doi.org/10.1016/j.jaci.2025.04.031
Vancouver
Jørgensen SF, Braadland PR, Ueland T, Fraz MSA, Michelsen AE, Holm K, et al. Tryptophan–kynurenine metabolites associate with inflammation and immunologic phenotypes in common variable immunodeficiency. Journal of Allergy and Clinical Immunology. 2025;156(3):814-824.e11. doi:10.1016/j.jaci.2025.04.031
BibTeX
@article{Jrgensen2025,
author = {Jørgensen, Silje F and Braadland, Peder R and Ueland, Thor and Fraz, Mai S A and Michelsen, Annika E and Holm, Kristian and Osnes, Liv T and Trøseid, Marius and Ueland, Per Magne and Fevang, Børre and Aukrust, Pål and Hov, Johannes R},
title = {Tryptophan–kynurenine metabolites associate with inflammation and immunologic phenotypes in common variable immunodeficiency},
journal = {Journal of Allergy and Clinical Immunology},
year = {2025},
volume = {156},
number = {3},
pages = {814--824.e11},
doi = {10.1016/j.jaci.2025.04.031}
}
EUVIMED